Vikram Verghese, an officer of Heartflow, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 3,587 shares of Heartflow common stock through Fidelity Brokerage Services LLC on NASDAQ:HTFL.

Key Highlights

  • Proposed sale: 3,587 shares of Heartflow common stock with an aggregate market value of $190,649.05, according to the filing.
  • Approximate sale date: November 9, 2026, executed through Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI 02917.
  • Shares outstanding: The filing states 86,953,627 shares of common stock were outstanding at the time of notice.
  • Source of shares: The shares were acquired via restricted stock vesting from the issuer: 2,744 shares on November 6, 2026, and 843 shares on November 7, 2026, both characterized as compensation.
  • Trading plan: The notice indicates reliance on a Rule 10b5-1 plan adopted on June 4, 2026.
  • Prior sales: The filing discloses eight sales of Heartflow common stock by Verghese between September 2 and September 18, 2026, totaling gross proceeds of approximately $4,951,989.37 across 99,376 shares.

Heartflow Officer Discloses Proposed Common Stock Sale Under Rule 144

Heartflow, Inc., headquartered at 135 Main Street, Suite 1000, San Francisco, California 94105, is the issuer of the securities described in this notice. The filing was submitted under SEC File Number 001-42790. Vikram Verghese, identified in the filing as an officer of the company, is the person for whose account the securities are proposed to be sold. The proposed sale of 3,587 shares carries an aggregate market value of $190,649.05, as stated in the filing.

According to the filing, the shares proposed for sale were acquired through restricted stock vesting directly from the issuer, classified as compensation. Specifically, 2,744 shares vested on November 6, 2026, and 843 shares vested on November 7, 2026. The notice was filed on November 9, 2026, and the filing indicates that the sale is intended to be executed on that same date through Fidelity Brokerage Services LLC on NASDAQ.

The filing also discloses that Verghese sold Heartflow common stock on eight separate dates during the three months prior to the notice. Those transactions, dated between September 2, 2026, and September 18, 2026, ranged from 668 shares generating gross proceeds of $5,034.54 to 29,714 shares generating gross proceeds of $1,487,459.84. The filing indicates the sale described in this notice is being conducted pursuant to a Rule 10b5-1 trading plan adopted on June 4, 2026. The notice was signed by Corey Walter as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Vikram Verghese.

What Was Disclosed

Heartflow officer Vikram Verghese filed a Form 144 notice proposing the sale of 3,587 shares of Heartflow common stock, acquired through restricted stock vesting as compensation, with an aggregate market value of $190,649.05, under a Rule 10b5-1 plan adopted June 4, 2026.